IPP Bureau

Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis

By IPP Bureau - April 13, 2022

The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa

USFDA grants direct RMAT designation for the use of ExoFlo in Covid-19 related ARDS
USFDA grants direct RMAT designation for the use of ExoFlo in Covid-19 related ARDS

By IPP Bureau - April 13, 2022

An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies
HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies

By IPP Bureau - April 13, 2022

Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases

Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells
Shoreline Biosciences showcases novel methodology to produce clinical scale iPSC-derived NK (iNK) cells

By IPP Bureau - April 13, 2022

Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production

Cloudbyz partners with ClinChoice to provide integrated clinical trial management solutions
Cloudbyz partners with ClinChoice to provide integrated clinical trial management solutions

By IPP Bureau - April 13, 2022

The joint partnership, powered by Cloudbyz Clinical Research Management Platform and ClinChoice's industry-leading transformation services, will provide an end-to-end clinical research management technology platform and services to customers

Novel Covid-19 vaccine may protect the immunocompromised
Novel Covid-19 vaccine may protect the immunocompromised

By IPP Bureau - April 13, 2022

The peptide-based vaccine induces a t cell-dependent response

WeylChem inaugurates new multi-purpose custom manufacturing plant in France
WeylChem inaugurates new multi-purpose custom manufacturing plant in France

By IPP Bureau - April 13, 2022

The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules

Zydus to supply Sagent's caffeine citrate oral solution from Jarod
Zydus to supply Sagent's caffeine citrate oral solution from Jarod

By IPP Bureau - April 13, 2022

This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants

Venus Remedies gets CII's Responsible Export Organisation Certification
Venus Remedies gets CII's Responsible Export Organisation Certification

By IPP Bureau - April 13, 2022

A comprehensive assessment of the organisational systems for governance, management, operations and consistency in delivered results, this certification is an endorsement of the company's export capabilities and manufacturing prowess

Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine
Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine

By IPP Bureau - April 13, 2022

Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland

Wacker, CordenPharma to produce mRNA vaccines for Germany
Wacker, CordenPharma to produce mRNA vaccines for Germany

By IPP Bureau - April 12, 2022

Both companies have been selected for stand-by production by German government

One-dose HPV vaccine offers solid protection against cervical cancer
One-dose HPV vaccine offers solid protection against cervical cancer

By IPP Bureau - April 12, 2022

This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls

Jorge Gomez joins Moderna as Chief Financial Officer
Jorge Gomez joins Moderna as Chief Financial Officer

By IPP Bureau - April 12, 2022

Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019

Carestream installs DRX Compass at Gati Diagnostic Centre
Carestream installs DRX Compass at Gati Diagnostic Centre

By IPP Bureau - April 12, 2022

The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers

PhableCare raises Rs 187 crore in Series B funding
PhableCare raises Rs 187 crore in Series B funding

By IPP Bureau - April 12, 2022

The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round

Latest Stories

Interviews

Packaging